OpenBind
@openbind.bsky.social
OpenBind is building the world’s largest open-access dataset of drug–protein interactions to speed up new treatments. Through cutting-edge science and open collaboration, we power AI tools for structure-based drug design – free for all.
#OpenBind has installed three new Crystal Shifter instruments to support Diamond Light Source’s #XChem #FragmentScreening and help drive the next generation of ML‑powered structure‑based #drug design. https://loom.ly/RRLB3V0),
January 16, 2026 at 12:10 PM
#OpenBind has installed three new Crystal Shifter instruments to support Diamond Light Source’s #XChem #FragmentScreening and help drive the next generation of ML‑powered structure‑based #drug design. https://loom.ly/RRLB3V0),
Reposted by OpenBind
At #CCP4 Study Weekend, Jasmin Aschenbrenner showcased #OpenBind - an initiative creating high-quality #FragmentScreening data at Diamond to power next-gen machine learning for #DrugDiscovery.
Learn more about this initiative:
Website: http://www.openbind.org
Bluesky: @openbind.bsky.social
Learn more about this initiative:
Website: http://www.openbind.org
Bluesky: @openbind.bsky.social
January 13, 2026 at 9:04 AM
At #CCP4 Study Weekend, Jasmin Aschenbrenner showcased #OpenBind - an initiative creating high-quality #FragmentScreening data at Diamond to power next-gen machine learning for #DrugDiscovery.
Learn more about this initiative:
Website: http://www.openbind.org
Bluesky: @openbind.bsky.social
Learn more about this initiative:
Website: http://www.openbind.org
Bluesky: @openbind.bsky.social
A big welcome to Jochem Nelen, who will be joining the #OpenBind initiative. Working with Fergus Imrie and Charlotte Deane at the University of Oxford to apply computational methods for better hit discovery and screening. https://loom.ly/Vro7Lo8 #OpenBind #DrugDiscovery #AI
January 14, 2026 at 9:35 AM
A big welcome to Jochem Nelen, who will be joining the #OpenBind initiative. Working with Fergus Imrie and Charlotte Deane at the University of Oxford to apply computational methods for better hit discovery and screening. https://loom.ly/Vro7Lo8 #OpenBind #DrugDiscovery #AI
Excited to welcome Ben Sattelle to the OpenBind team! Ben will be working at MedChemica to link MCPairs with SCARAB, driving AI-powered drug discovery and smarter molecular design. Find out more: https://loom.ly/Vro7Lo8 #OpenBind #DrugDiscovery #AI
January 13, 2026 at 12:15 PM
Excited to welcome Ben Sattelle to the OpenBind team! Ben will be working at MedChemica to link MCPairs with SCARAB, driving AI-powered drug discovery and smarter molecular design. Find out more: https://loom.ly/Vro7Lo8 #OpenBind #DrugDiscovery #AI
We've completed the first experimental phasing cycle!
January 9, 2026 at 12:01 PM
We've completed the first experimental phasing cycle!
Heading to #CCP4 this week? Discover #OpenBind, an open science initiative transforming structure-based drug design. Join Fergus Imrie (University of Oxford) on Friday, 11:00–11:30, to learn how OpenBind powers next-generation machine learning for #DrugDiscovery: https://loom.ly/KxbknFk
January 7, 2026 at 12:12 PM
Heading to #CCP4 this week? Discover #OpenBind, an open science initiative transforming structure-based drug design. Join Fergus Imrie (University of Oxford) on Friday, 11:00–11:30, to learn how OpenBind powers next-generation machine learning for #DrugDiscovery: https://loom.ly/KxbknFk
Join our mailing list for early access to AI-driven drug discovery insights & breakthroughs through the #OpenBind initiative. https://loom.ly/Vro7Lo8
January 6, 2026 at 5:22 PM
Join our mailing list for early access to AI-driven drug discovery insights & breakthroughs through the #OpenBind initiative. https://loom.ly/Vro7Lo8